BMS may help reduce heart failure-related risk factors
Metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage...
BMS may help reduce heart failure-related risk factors
BMS may help reduce heart failure-related risk factors
BMS may help reduce heart failure-related risk factors
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour
Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours
Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss
Journal Watch 6/11/2024
Omada survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals
Cytoki Pharma doses first patient in Phase 2 study of CK-0045 for obesity and T2DM
Endevica Bio spins off new company Abisati to develop weight loss drug
STEP 9: Semaglutide reduces knee osteoarthritis-related pain in people with obesity
Palatin completes study enrolment of bremelanotide plus tirzepatide to treat obesity
TENN-LABS: Ten-year outcomes show long-term benefits of surgery in young people
GT Metabolic's MagDI System for side-to-side DI anastomosis to "revolutionise industry" after FDA approval